| scholarly article | Q13442814 |
| P2093 | author name string | James C Fuscoe | |
| Robert R Delongchamp | |||
| Taewon Lee | |||
| Varsha G Desai | |||
| Cruz Velasco | |||
| P2860 | cites work | A threshold neurotoxic amphetamine exposure inhibits parietal cortex expression of synaptic plasticity-related genes | Q23914101 |
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Assessing gene significance from cDNA microarray expression data via mixed models | Q29616338 | ||
| Modeling of DNA microarray data by using physical properties of hybridization | Q30803659 | ||
| Analysis of variance components in gene expression data | Q30904834 | ||
| Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data | Q30939430 | ||
| Multiple-testing strategy for analyzing cDNA array data on gene expression | Q30955439 | ||
| Development of mitochondria-specific mouse oligonucleotide microarray and validation of data by real-time PCR. | Q31113739 | ||
| Genome-wide estimation of gender differences in the gene expression of human livers: statistical design and analysis | Q33219776 | ||
| Microarray data analysis: from disarray to consolidation and consensus | Q33230059 | ||
| A method for computing the overall statistical significance of a treatment effect among a group of genes | Q33264191 | ||
| Microarrays and toxicology: the advent of toxicogenomics | Q33594789 | ||
| An overview of toxicogenomics. | Q34586764 | ||
| The promise of toxicogenomics. | Q34760252 | ||
| Design issues for cDNA microarray experiments | Q34770425 | ||
| Application of DNA microarrays in pharmacogenomics and toxicogenomics | Q35043479 | ||
| Questions and answers on design of dual-label microarrays for identifying differentially expressed genes | Q35226477 | ||
| Toxicogenomic approach for assessing toxicant-related disease | Q35596084 | ||
| Toxicogenomics in drug development | Q35614775 | ||
| Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit? | Q36144296 | ||
| Application of genomics in preclinical drug safety evaluation | Q36478801 | ||
| Free energy of DNA duplex formation on short oligonucleotide microarrays | Q38306514 | ||
| Changes in expression level of genes as a function of time of day in the liver of rats | Q38341824 | ||
| An experimental evaluation of a loop versus a reference design for two-channel microarrays | Q40514819 | ||
| Relationship between gene expression and observed intensities in DNA microarrays--a modeling study | Q41853296 | ||
| A statistical approach in using cDNA array analysis to determine modest changes in gene expression in several brain regions after neurotoxic insult | Q44508357 | ||
| A random variance model for detection of differential gene expression in small microarray experiments | Q47328113 | ||
| Sample size for gene expression microarray experiments | Q47399991 | ||
| Statistical design of reverse dye microarrays | Q47941786 | ||
| Evaluation of the gene-specific dye bias in cDNA microarray experiments | Q48499684 | ||
| Answer to the comments of K. Dobbin, J. Shih and R. Simon on the paper 'Evaluation of the gene-specific dye-bias in cDNA microarray experiments'. | Q51971952 | ||
| Comment on 'Evaluation of the gene-specific dye bias in cDNA microarray experiments'. | Q51976553 | ||
| Experimental design for gene expression microarrays | Q73838409 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toxicogenomics | Q841450 |
| P304 | page(s) | 317-28 | |
| P577 | publication date | 2008-08-14 | |
| P1433 | published in | Bioinformatics and Biology Insights | Q4914913 |
| P1476 | title | Designing toxicogenomics studies that use DNA array technology | |
| P478 | volume | 2 |
| Q33369618 | Testing for treatment effects on gene ontology. | cites work | P2860 |
Search more.